Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2013, Article ID 383681, 9 pages
http://dx.doi.org/10.1155/2013/383681
Research Article

PADI4 Haplotypes in Association with RA Mexican Patients, a New Prospect for Antigen Modulation

1Programa Internacional del ICB, Facultad de Medicina, Universidad Autónoma de Guadalajara, Guadalajara, JAL, Mexico
2Unidad de Investigación en Epidemiología Clínica, Hospital de Especialidades, Centro Médico Nacional de Occidente del Instituto Mexicano del Seguro Social, Guadalajara, JAL, Mexico
3División de Medicina Molecular del Centro de Investigación Biomédica de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, JAL, Mexico
4Departamento de Medicina Interna-Reumatología del Hospital General Regional No. 110, Instituto Mexicano del Seguro Social, Guadalajara, JAL, Mexico
5División de Genética, CIBO, IMSS and Instituto de Genética Humana, CUCS Universidad de Guadalajara, Guadalajara, JAL, Mexico
6División de Investigación en Salud, UMAE, Hospital de Especialidades, CMNO, IMSS and Departamento de Fisiología, CUCS, Universidad de Guadalajara, Mexico

Received 31 May 2013; Revised 5 September 2013; Accepted 23 September 2013

Academic Editor: Timothy B. Niewold

Copyright © 2013 Maria Guadalupe Zavala-Cerna et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. M. Abdel-Nasser, J. J. Rasker, and H. A. Valkenburg, “Epidemiological and clinical aspects relating to the variability of rheumatoid arthritis,” Seminars in Arthritis and Rheumatism, vol. 27, no. 2, pp. 123–140, 1997. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Alamanos and A. A. Drosos, “Epidemiology of adult rheumatoid arthritis,” Autoimmunity Reviews, vol. 4, no. 3, pp. 130–136, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. G. S. Firestein, “Evolving concepts of rheumatoid arthritis,” Nature, vol. 423, no. 6937, pp. 356–361, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. S. A. Ahmed, B. D. Hissong, D. Verthelyi, K. Donner, K. Becker, and E. Karpuzoglu-Sahin, “Gender and risk of autoimmune diseases: possible role of estrogenic compounds,” Environmental Health Perspectives, vol. 107, supplement 5, pp. 681–686, 1999. View at Google Scholar · View at Scopus
  5. R. M. Nakamura, “Progress in the use of biochemical and biological markers for evaluation of rheumatoid arthritis,” Journal of Clinical Laboratory Analysis, vol. 14, no. 6, pp. 305–313, 2000. View at Google Scholar
  6. D. L. Mattey, W. Thomson, W. E. R. Ollier et al., “Association of DRB1 shared epitope genotypes with early mortality in rheumatoid arthritis: results of eighteen years of followup from the early rheumatoid arthritis study,” Arthritis and Rheumatism, vol. 56, no. 5, pp. 1408–1416, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. F. A. van Gaalen, J. van Aken, T. W. J. Huizinga et al., “Association between HLA class II genes and autoantibodies to Cyclic Citrullinated Peptides (CCPs) influences the severity of rheumatoid arthritis,” Arthritis and Rheumatism, vol. 50, no. 7, pp. 2113–2121, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. C. M. Deighton, D. J. Walker, I. D. Griffiths, and D. F. Roberts, “The contribution of HLA to rheumatoid arthritis,” Clinical Genetics, vol. 36, no. 3, pp. 178–182, 1989. View at Google Scholar · View at Scopus
  9. A. Suzuki, R. Yamada, X. Chang et al., “Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis,” Nature Genetics, vol. 34, no. 4, pp. 395–402, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. E. R. Vossenaar, T. J. M. Smeets, M. C. Kraan, J. M. Raats, W. J. van Venrooij, and P. P. Tak, “The presence of citrullinated proteins is not specific for rheumatoid synovial tissue,” Arthritis and Rheumatism, vol. 50, no. 11, pp. 3485–3494, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Hoppe, T. Haupl, R. Gruber et al., “Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case-control study,” Arthritis Research & Therapy, vol. 8, no. 2, article R34, 2006. View at Publisher · View at Google Scholar
  12. S. M. J. Harney, C. Meisel, A.-M. Sims, P. Y. Woon, B. P. Wordsworth, and M. A. Brown, “Genetic and genomic studies of PADI4 in rheumatoid arthritis,” Rheumatology, vol. 44, no. 7, pp. 869–872, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Luo, K. Arita, M. Bhatia et al., “Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization,” Biochemistry, vol. 45, no. 39, pp. 11727–11736, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Nakashima, T. Hagiwara, and M. Yamada, “Nuclear localization of peptidylarginine deiminase V and histone deimination in granulocytes,” Journal of Biological Chemistry, vol. 277, no. 51, pp. 49562–49568, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Senshu, S. Kan, H. Ogawa, M. Manabe, and H. Asaga, “Preferential deimination of keratin K1 and filaggrin during the terminal differentiation of human epidermis,” Biochemical and Biophysical Research Communications, vol. 225, no. 3, pp. 712–719, 1996. View at Publisher · View at Google Scholar · View at Scopus
  16. L. B. Pritzker, T. A. Nguyen, and M. A. Moscarello, “The developmental expression and activity of peptidylarginine deiminase in the mouse,” Neuroscience Letters, vol. 266, no. 3, pp. 161–164, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Wang, M. Li, S. Stadler et al., “Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation,” Journal of Cell Biology, vol. 184, no. 2, pp. 205–213, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. R. S. Lewis, “Calcium signaling mechanisms in T lymphocytes,” Annual Review of Immunology, vol. 19, pp. 497–521, 2001. View at Google Scholar
  19. M. E. Stensland, S. Pollmann, Ø. Molberg, L. M. Sollid, and B. Fleckenstein, “Primary sequence, together with other factors, influence peptide deimination by peptidylarginine deiminase-4,” Biological Chemistry, vol. 390, no. 2, pp. 99–107, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. E. R. Vossenaar, T. R. D. Radstake, A. van der Heijden et al., “Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages,” Annals of the Rheumatic Diseases, vol. 63, no. 4, pp. 373–381, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Klareskog, M. Widhe, M. Hermansson, and J. Ronnelid, “Antibodies to citrullinated proteins in arthritis: pathology and promise,” Current Opinion in Rheumatology, vol. 20, no. 3, pp. 300–305, 2008. View at Publisher · View at Google Scholar
  22. S. Rantapää-Dahlqvist, B. A. W. de Jong, E. Berglin et al., “Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis,” Arthritis and Rheumatism, vol. 48, no. 10, pp. 2741–2749, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. M. M. J. Nielen, D. van Schaardenburg, H. W. Reesink et al., “Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors,” Arthritis and Rheumatism, vol. 50, no. 2, pp. 380–386, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. F. A. van Gaalen, S. P. Linn-Rasker, W. J. van Venrooij et al., “Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study,” Arthritis and Rheumatism, vol. 50, no. 3, pp. 709–715, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Kastbom, G. Strandberg, A. Lindroos, and T. Skogh, “Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project),” Annals of the Rheumatic Diseases, vol. 63, no. 9, pp. 1085–1089, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Ikari, M. Kuwahara, T. Nakamura et al., “Association between PADI4 and rheumatoid arthritis: a replication study,” Arthritis and Rheumatism, vol. 52, no. 10, pp. 3054–3057, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Barton, J. Bowes, S. Eyre et al., “A functional haplotype of the PADI4 gene associated with rheumatoid arthritis in a Japanese population is not associated in a United Kingdom population,” Arthritis and Rheumatism, vol. 50, no. 4, pp. 1117–1121, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Caponi, E. Petit-Teixeira, M. Sebbag et al., “A family based study shows no association between rheumatoid arthritis and the PADI4 gene in a white French population,” Annals of the Rheumatic Diseases, vol. 64, no. 4, pp. 587–593, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Martinez, A. Valdivia, D. Pascual-Salcedo et al., “PADI4 polymorphisms are not associated with rheumatoid arthritis in the Spanish population,” Rheumatology, vol. 44, no. 10, pp. 1263–1266, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. F. C. Arnett, S. M. Edworthy, D. A. Bloch et al., “The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis,” Arthritis and Rheumatism, vol. 31, no. 3, pp. 315–324, 1988. View at Google Scholar · View at Scopus
  31. M. L. L. Prevoo, M. A. van'T Hof, H. H. Kuper, M. A. van Leeuwen, L. B. A. van de Putte, and P. L. C. M. van Riel, “Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis,” Arthritis and Rheumatism, vol. 38, no. 1, pp. 44–48, 1995. View at Publisher · View at Google Scholar · View at Scopus
  32. M. H. Cardiel, M. Abello-Banfi, R. Ruiz-Mercado, and D. Alarcon-Segovia, “How to measure health status in rheumatoid arthritis in non-English speaking patients: validation of a Spanish version of the Health Assessment Questionnaire Disability Index (Spanish HAQ-DI),” Clinical and Experimental Rheumatology, vol. 11, no. 2, pp. 117–121, 1993. View at Google Scholar
  33. G. Ting, S. Schneeweiss, J. N. Katz et al., “Performance of a rheumatoid arthritis records-based index of severity,” Journal of Rheumatology, vol. 32, no. 9, pp. 1679–1687, 2005. View at Google Scholar · View at Scopus
  34. S. Gustincich, G. Manfioletti, G. Del Sal, C. Schneider, and P. Carninci, “A fast method for high-quality genomic DNA extraction from whole human blood,” BioTechniques, vol. 11, no. 3, pp. 298–302, 1991. View at Google Scholar · View at Scopus
  35. M. Stephens, N. J. Smith, and P. Donnelly, “A new statistical method for haplotype reconstruction from population data,” American Journal of Human Genetics, vol. 68, pp. 978–989, 2001. View at Google Scholar
  36. A. K. Abbas and A. H. Lichtman, Basic Immunology: Functions and Disorders of the Immune System, WB Saunders, Philadelphia, Pa, USA, 2nd edition, 2004.
  37. P. Matzinger, “The danger model: a renewed sense of self,” Science, vol. 296, no. 5566, pp. 301–305, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. K. L. Rock and H. Kono, “The inflammatory response to cell death,” Annual Review of Pathology, vol. 3, pp. 99–126, 2008. View at Google Scholar
  39. H. Kono and K. L. Rock, “How dying cells alert the immune system to danger,” Nature Reviews Immunology, vol. 8, no. 4, pp. 279–289, 2008. View at Publisher · View at Google Scholar
  40. F. Martinon, K. Burns, and J. Tschopp, “The Inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β,” Molecular Cell, vol. 10, no. 2, pp. 417–426, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. F. Martinon, A. Mayor, and J. Tschopp, “The inflammasomes: guardians of the body,” Annual Review of Immunology, vol. 27, pp. 229–265, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. C. M. Weyand and J. J. Goronzy, “Pathogenesis of rheumatoid arthritis,” Medical Clinics of North America, vol. 81, no. 1, pp. 29–55, 1997. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Iwamoto, K. Ikari, T. Nakamura et al., “Association between PADI4 and rheumatoid arthritis: a meta-analysis,” Rheumatology, vol. 45, no. 7, pp. 804–807, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. H. Lee, Y. H. Rho, S. J. Choi, J. D. Ji, and G. G. Song, “PADI4 polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis,” Rheumatology International, vol. 27, no. 9, pp. 827–833, 2007. View at Google Scholar
  45. C. Gorodezky, C. Alaez, M. N. Vázquez-García et al., “The genetic structure of Mexican Mestizos of different locations: tracking back their origins through MHC genes, blood group systems, and microsatellites,” Human Immunology, vol. 62, no. 9, pp. 979–991, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. B. Hoppe, G. A. Heymann, F. Tolou, H. Kiesewetter, T. Doerner, and A. Salama, “High variability of peptidylarginine deiminase 4 (PADI4) in a healthy white population: characterization of six new variants of PADI4 exons 2-4 by a novel haplotype-specific sequencing-based approach,” Journal of Molecular Medicine, vol. 82, no. 11, pp. 762–767, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. C. P. Kang, H.-S. Lee, H. Ju, H. Cho, C. Kang, and S.-C. Bae, “A functional haplotype of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Koreans,” Arthritis and Rheumatism, vol. 54, no. 1, pp. 90–96, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. F. Gandjbakhch, I. Fajardy, B. Ferré et al., “A functional haplotype of PADI4 gene in rheumatoid arthritis: positive correlation in a french population,” Journal of Rheumatology, vol. 36, no. 5, pp. 881–886, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. G. A. Schellekens, H. Visser, B. A. de Jong et al., “The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide,” Arthritis and Rheumatism, vol. 43, no. 1, pp. 155–163, 2000. View at Google Scholar
  50. M. G. Zavala-Cerna, A. Nava, E. Garcia-Castaneda, J. Duran-Gonzalez, M. J. Arias-Merino, and M. Salazar-Paramo, “Serum IgG activity against cyclic citrullinated peptide in patients evaluated for rheumatoid factor correlates with the IgM isotype,” Rheumatology International, vol. 28, no. 9, pp. 851–857, 2008. View at Publisher · View at Google Scholar
  51. G. Lakos, L. Soos, A. Fekete et al., “Anti-cyclic citrullinated peptide antibody isotypes in rheumatoid arthritis: association with disease duration, rheumatoid factor production and the presence of shared epitope,” Clinical and Experimental Rheumatology, vol. 26, no. 2, pp. 253–260, 2008. View at Google Scholar
  52. K. N. Verpoort, C. M. Jol-van der Zijde, E. A. M. Papendrecht-van der Voort et al., “Isotype distribution of anti-cyclic citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response,” Arthritis and Rheumatism, vol. 54, no. 12, pp. 3799–3808, 2006. View at Publisher · View at Google Scholar · View at Scopus
  53. D. Makrygiannakis, E. Af Klint, I. E. Lundberg et al., “Citrullination is an inflammation-dependent process,” Annals of the Rheumatic Diseases, vol. 65, no. 9, pp. 1219–1222, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. J. A. Hill, S. Southwood, A. Sette, A. M. Jevnikar, D. A. Bell, and E. Cairns, “Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule,” Journal of Immunology, vol. 171, no. 2, pp. 538–541, 2003. View at Google Scholar · View at Scopus
  55. R. M. Plenge, L. Padyukov, E. F. Remmers et al., “Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4,” American Journal of Human Genetics, vol. 77, no. 6, pp. 1044–1060, 2005. View at Publisher · View at Google Scholar · View at Scopus